title: [Nerve conduction velocity following high-dose vincristine in the treatment of small cell bronchial cancer].
abstract: The bicyclic alternating therapeutic regimen employing high-dose vincristine results in very high response rates at acceptable levels of adverse reactions. Neither the motor nor the sensory NCV is significantly influenced by this form of treatment.
authors.affiliation: Abteilung für Pneumologie, Medizinische Klinik und Poliklinik, Universitätskliniken Homburg/Saar.
authors.forename: F
authors.initials: F
authors.lastname: Eich
authors.forename: W
authors.initials: W
authors.lastname: Emser
authors.forename: G W
authors.initials: GW
authors.lastname: Sybrecht
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011930:Reaction Time / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D015251:Epirubicin; D014750:Vincristine; D005047:Etoposide; D003520:Cyclophosphamide; D002945:Cisplatin
vernacular_title: Nervenleitgeschwindigkeit (NLG) nach high-dose Vincristin in der Behandlung des kleinzelligen Bronchialkarzinoms (SCLC).